These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 26317978

  • 21. Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
    Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM, HALT-C Trial Group.
    Hepatology; 2008 Nov; 48(5):1412-9. PubMed ID: 18816437
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population.
    Zuberi BF, Zuberi FF, Memon SA, Qureshi MH, Ali SZ, Afsar S.
    World J Gastroenterol; 2008 Apr 14; 14(14):2218-21. PubMed ID: 18407597
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Trace amounts of sporadically reappearing HCV RNA can cause infection.
    Veerapu NS, Park SH, Tully DC, Allen TM, Rehermann B.
    J Clin Invest; 2014 Aug 14; 124(8):3469-78. PubMed ID: 25003189
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Performance of molecular methods for hepatitis C virus diagnosis: usefulness among chronic cases and during the course of infection.
    Martins PP, Lampe E, Lewis-Ximenez LL, de Souza PS, Fernandes CA, Villar LM.
    Clin Lab; 2013 Aug 14; 59(9-10):1031-9. PubMed ID: 24273925
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.
    Chevaliez S, Feld J, Cheng K, Wedemeyer H, Sarrazin C, Maasoumy B, Herman C, Hackett J, Cohen D, Dawson G, Pawlotsky JM, Cloherty G.
    Antivir Ther; 2018 Aug 14; 23(3):211-217. PubMed ID: 27115431
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.
    Dalgard O, Martinot-Peignoux M, Verbaan H, Bjøro K, Ring-Larsen H, Marcellin P.
    PLoS One; 2015 Aug 14; 10(8):e0120866. PubMed ID: 26317978
    [Abstract] [Full Text] [Related]

  • 40. Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.
    Baleriola C, Rawlinson WD, Dore GJ, Chaverot S, Stelzer-Braid S, Yoshihara M, Crawford D, Sievert W, McCaughan G, Weltman M, Cheng W, Rizkalla B, Dubois D, Thommes J, Roberts S.
    Antivir Ther; 2011 Aug 14; 16(2):173-80. PubMed ID: 21447866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.